NASDAQ:ATRI - Atrion Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$795.00 +5.49 (+0.70 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$789.51
Today's Range$791.89 - $795.00
52-Week Range$516.85 - $803.00
Volume3,604 shs
Average Volume8,116 shs
Market Capitalization$1.47 billion
P/E Ratio41.68
Dividend Yield0.68%
Beta0.45
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$146.60 million
Cash Flow$23.4513 per share
Book Value$99.57 per share

Profitability

Net Income$36.59 million

Miscellaneous

Employees528
Market Cap$1.47 billion
OptionableNot Optionable

Atrion (NASDAQ:ATRI) Frequently Asked Questions

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Monday, November 12th. Stockholders of record on Monday, December 3rd will be given a dividend of $1.35 per share on Monday, December 17th. This represents a $5.40 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Friday, November 30th. View Atrion's Dividend History.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings data on Tuesday, February, 27th. The medical instruments supplier reported $4.66 EPS for the quarter. The medical instruments supplier earned $34.02 million during the quarter. Atrion had a return on equity of 18.01% and a net margin of 23.19%. View Atrion's Earnings History.

When is Atrion's next earnings date?

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Atrion.

Has Atrion been receiving favorable news coverage?

Media headlines about ATRI stock have trended positive this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Atrion earned a coverage optimism score of 2.3 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the near term.

Who are some of Atrion's key competitors?

Who are Atrion's key executives?

Atrion's management team includes the folowing people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Sec. & Treasurer (Age 60)

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.33%), Kayne Anderson Rudnick Investment Management LLC (5.05%), Dimensional Fund Advisors LP (3.44%), Royce & Associates LP (2.04%), Northern Trust Corp (1.15%) and Geode Capital Management LLC (0.97%). Company insiders that own Atrion stock include Emile A Battat and Jeffery Strickland. View Institutional Ownership Trends for Atrion.

Which institutional investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Prudential Financial Inc., Royce & Associates LP, Bank of New York Mellon Corp, Denali Advisors LLC, Thomson Horstmann & Bryant Inc., Barclays PLC and MetLife Investment Advisors LLC. View Insider Buying and Selling for Atrion.

Which institutional investors are buying Atrion stock?

ATRI stock was bought by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Bessemer Group Inc., KAMES CAPITAL plc, BlackRock Inc., Virginia Retirement Systems ET AL, Martingale Asset Management L P, Laurel Wealth Advisors LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for Atrion.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $795.00.

How big of a company is Atrion?

Atrion has a market capitalization of $1.47 billion and generates $146.60 million in revenue each year. Atrion employs 528 workers across the globe.

What is Atrion's official website?

The official website for Atrion is http://www.atrioncorp.com.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]


MarketBeat Community Rating for Atrion (NASDAQ ATRI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel